Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CYP4F2///CYP4F3 |
| Upstream (Parents) |
|---|
| (<<) MAT1A → CYP4F2///CYP4F3 |
| (<<) NR1H4 → CYP4F2///CYP4F3 |
| (<<) CYP4F2 → CYP4F2///CYP4F3 |
| (<<) CYP4F3 → CYP4F2///CYP4F3 |
| Downstream (Children) |
|---|
| CYP4F2///CYP4F3 → C22orf46 (>>) |
| CYP4F2///CYP4F3 → GPR1 (>>) |
| CYP4F2///CYP4F3 → IBTK (>>) |
| CYP4F2///CYP4F3 → CYP4F2 (>>) |
| CYP4F2///CYP4F3 → DDO (>>) |
| CYP4F2///CYP4F3 → MBL1P (>>) |
| CYP4F2///CYP4F3 → LRRC2 (>>) |
